Broad-spectrum vaccines might be one useful place to look. Just last year, there was this paper on a universal flu vaccine. The numbers aren't super-impressive, but they're significant, and the study itself used a peptide vaccine. (See also this paper, or this page on a broad-spectrum vaccine against bacteria, which I didn't even know was a thing.)

A more speculative category might be therapeutic cancer vaccines. Some of these are tailored to one person's existing cancer, so they only make sense for someone with the disease. But my understanding is that some of them target common cancer antigens, so in-principle they could be used preventatively. (Seems like the magic word to search for here is "neoantigens".)

On the ultra-speculative and potentially-dangerous end of the spectrum, I have wondered before if a vaccine could make the immune system attack cells with transposon activity. Note that both this and cancer vaccines involve getting the immune system to attack one's own cells, which makes them both difficult and dangerous. But the rewards could potentially be quite large: transposons are top-of-list of likely root causes of the major age-related diseases (including cancer itself). For instance, this page mentions a current project to develop "transposon-derived neoantigens" for cancer vaccines, and that's exactly the sort of thing which would potentially be effective against other diseases of aging as well.

Also, I've heard there are reasons to ingest peptides other than just vaccines. I don't know much about other applications, though.

There are other coronavirus types that cause the common cold. If this type of peptide vaccine is effective in protecting against the novel coronavirus, it might work for the older types as well, if made with the appropriate peptides, of course.

Until we have better data on the immune response to this type of vaccine, I wouldn't want to quit conventional vaccinations or try to fully replace them with radvac. I'd consider diy vaccines a likely improvement for supplementing traditional vaccines in the cases of respiratory infections that mutate too fast for commercial vaccines and respiratory infections that are too rare or localized for big manufacturers to bother making vaccines against them, though.

I would want to see more data on the safety of the process before using nasal peptides against non-respiratory infections, because my mental model of the immune system explains some of its malfunctions as the system freaking out over seeing something it's acquainted with in an unusual context. These examples include the way that beekeepers can suddenly develop an anaphylactic reaction to being stung after years of being stung with no problems, and a model of childhood food allergy in which children exposed to an allergen by skin contact before they eat it are more likely to have a reaction when eating it.

It's 2020 hindsight to suggest that it would have made sense to snort covid peptides as soon as its genome was sequenced, though. I recall a lot of early confusion about whether it would be possible to develop safe and effective vaccines for it, because some people were seeing patterns in the data that looked like the more severe symptoms might be caused by an immune response developed by earlier and milder exposure to the virus. I don't think that possibility was truly ruled out until data from commercial vaccine trials became available. Given what was known at this time last year, for instance, I don't think the expected benefits of snorting covid peptides would have necessarily outweighed the likely-looking drawbacks. Once the other vaccine data was out, though, there were far fewer reasons not to try to self-vaccinate.

I've always wondered if it could be used for organic fungal toxins and other common airborne hazards

Gum disease. While oral pathogens are mostly bacteria, they're also excellent at evading and even subverting the natural immune response. Considering the likelihood that human diets will continue to contain large amounts of carbohydrates for the foreseeable future, gum disease represents a very large and growing cause of both morbidity and economic burden for people in all economic situations. Targeting key bacterial species or even maladaptive human immune activity could save everyone money, pain, and increase the day-to-day well-being of a majority of humans in perpetuity.